Bio Nebraska and Pfizer Host 1st Collaborative Bio Innovation Conference

(Omaha, NE; Tuesday, December 23, 2008) – Bio Nebraska Life Sciences Association hosted
a Bio Innovation Conference in partnership with Pfizer on Friday, December 19, 2008, at the
Pfizer Global Manufacturing Facility in Lincoln, Nebraska. The event was open to members of
the life sciences trade association and focused on biotechnological innovations within the state
and beyond.

“Bio Nebraska provides the opportunity for all of those involved in the life sciences to
propel the activity within our state and individual companies. This event provides a forum for
industry, government and academia to come together to discuss innovations making an impact
in our industry,” stated Jim McClurg, PhD, chairman, Bio Nebraska Life Sciences Association.
“We were honored to have Governor Dave Heineman and the other keynote speakers address
our audience.”

The Bio Innovation Conference was organized by Paul Plofchan, director, government
relations of Pfizer Inc., in partnership with Amy Recker, executive director of Bio Nebraska.
Keynote speakers included: Congressman Jeff Fortenberry “Bio Investment and Trade—A
Federal Perspective”; Dan Martz, vice president, public affairs and communications, Pfizer
Animal Health with an animal health update; Christine Smith, vice president, Pfizer Global
Research and Development, Biotherapeutics Center of Emphasis “The Long Road to a New
Medicine and the Value of Medical Innovation”; and remarks by Governor Dave Heineman.

About Bio Nebraska
The mission of Bio Nebraska is to be the champion of biotechnology and to advocate for its member
organizations promoting academic, industry and government partnerships to foster the growth of life
sciences within Nebraska. Nebraska biotechnology researchers expand the boundaries of science to
benefit man-kind by providing better healthcare, enhanced agriculture, and a cleaner and safer
environment, hence creating opportunities for economic development within the state.